Prospective follow-up of patients with acute hepatitis c virus infection in Brazil

Clinical Infectious Diseases

Volumn 50, Issue 9, 2010, Pages 1222-1230

  Lewis Ximenez, Lia L ^a   Lauer, Georg M ^f   Wiesch, Julian Schulze Zur ^h   De Sousa, Paulo Sergio Fonseca ^a   Ginuino, Cleber F ^a   Paranhos Baccalá, Gláucia ⁱ   Ulmer, Hanno ^j   Pfeiffer, Karl P ^j   Goebel, Georg ^j   Pereira, João Luiz ^b   De Oliveira, Jaqueline Mendes ^a   Yoshida, Clara Fumiko Tachibana ^a   Lampe, Elisabeth ^a   Velloso, Carlos Eduardo ^a   Pinto, Marcelo Alves ^a   Coelho, Henrique Sergio ^c   Almeida, Adilson José ^a,d   Fernandes, Carlos Augusto ^e   Kim, Arthur Y ^g   Strasak, Alexander M ^j  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b HOSPITAL GERAL DE BONSUCESSO   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d HOSPITAL UNIVERSITÁRIO GAFFRÉE E GUINLE   (Brazil)

^e Hepatitis Division   (Brazil)

^f Gastrointestinal Unit   (Norway)

^g HARVARD MEDICAL SCHOOL   (United States)

^h UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

ⁱ Laboratory of Emerging Pathogens and Christoph Merieux Laboratory   (France)

^j INNSBRUCK MEDICAL UNIVERSITY   (Austria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; RNA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BRAZIL; CHRONIC DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HAZARD RATIO; HEPATITIS C; HEPATITIS C VIRUS; HOST; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; VIRUS LOAD;

ADULT; AGED; ALANINE TRANSAMINASE; BRAZIL; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RNA, VIRAL; YOUNG ADULT;

EID: 77950985536     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/651599     Document Type: Article

References (38)

1. Kamal SM. Acute hepatitis C: a systematic review. Am J Gastroenterol 2008;103:1283-1297.
2. Maheshwari A, Ray S, Thuluvath PJ. Acute hepatitis C. Lancet 2008; 372:321-332.
3. Blackard JT, Shata MT, Shire NJ, Sherman KE. Acute hepatitis C virus infection: a chronic problem. Hepatology 2008;47:321-331. (Pubitemid 351171069)
4. The Global Burden of Hepatitis C Working Group. Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol 2004;44:20-29.
5. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144:705-714.
6. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005; 5:558-567. (Pubitemid 41196755)
7. Thomas DL, Seeff LB. Natural history of hepatitis C. Clin Liver Dis 2005;9:383-398.
8. Chung RT. Acute hepatitis C virus infection. Clin Infect Dis 2005; 41(suppl 1):S14-S17.
9. Seeff LB, Hoofnagle JH. The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002. Clin Liver Dis 2003;7:261-287.
10. Mazzeo C, Azzaroli F, Giovanelli S, et al. Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance. Gut 2003;52:1030-1034. (Pubitemid 36765297)
11. Micallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat 2006; 13:34-41.
12. Cox AL, Netski DM, Mosbruger T, et al. Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clin Infect Dis 2005;40:951-958.
13. Corey KE, Ross AS, Wurcel A, et al. Outcomes and treatment of acute hepatitis C virus infection in a United States population. Clin Gastroenterol Hepatol 2006;4:1278-1282.
14. Mondelli MU, Cerino A, Cividini A. Acute hepatitis C: diagnosis and management. J Hepatol 2005;42(suppl 1):S108-S114.
15. Santantonio T, Medda E, Ferrari C, et al. Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy. Clin Infect Dis 2006;43:1154-1159.
16. Hofer H, Watkins-Riedel T, Janata O, et al. Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load. Hepatology 2003;37:60-64. (Pubitemid 36042145)
17. Minola E, Baldo V, Baldovin T, Trivello R, Floreani A. Intrafamilial transmission of hepatitis C virus infection. Eur J Epidemiol 2006; 21: 293-297. (Pubitemid 43725487)
18. Santantonio T, Sinisi E, Guastadisegni A, et al. Natural course of acute hepatitis C: a long-term prospective study. Dig Liver Dis 2003; 35: 104-113. (Pubitemid 41490321)
19. Orland JR, Wright TL, Cooper S. Acute hepatitis C. Hepatology 2001;33:321-327.
20. 20. Jee LJ. Host genetic determinants in hepatitis C virus infection. Genes Immun 2004;5:237-245. (Pubitemid 38967177)
21. 21. Singh R, Kaul R, Kaul A, Khan K. A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroenterol 2007;13:1770-1787. (Pubitemid 46706009)
22. 22. Gerlach JT, Diepolder HM, Zachoval R, et al. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 2003; 125:80-88. (Pubitemid 36799109)
23. 23. Wang C, Krantz E, Klarquist J, et al. Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance. J Infect Dis 2007; 196:1474-1482. (Pubitemid 351411983)
24. 24. Amin J, Law MG, Micallef J, et al. Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users. Epidemiol Infect 2007; 135: 144-150. (Pubitemid 44811499)
25. Sharaf Eldin N, Ismail S, Mansour H, et al. Symptomatic acute hepatitis C in Egypt: diagnosis, spontaneous viral clearance, and delayed treatment with 12 weeks of pegylated interferon alfa-2a. PLoS One 2008; 3(12):e4085.
26. 26. Netski DM, Mosbruger T, Depla E, et al. Humoral immune response in acute hepatitis C virus infection. Clin Infect Dis 2005;41:667-675. (Pubitemid 41170355)
27. McGovern BH, Birch CE, Bowen MJ, et al. Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria. Clin Infect Dis 2009;49:1051-1060.
28. 28. Komurian-Pradel F, Paranhos-Baccalà G, Sodoyer M, et al. Quantitation of HCV RNA using real-time PCR and fluorimetry. J Virol Methods 2001;95:111-119. (Pubitemid 32493842)
29. 29. Schulze Zur Wiesch J, Lauer GM, Timm J, et al. Immunologie evidence for lack of heterologous protection following resolution of HCV in patients with non-genotype 1 infection. Blood 2007;110:1559-1569. (Pubitemid 47443972)
30. Page K, Hahn JA, Evans J, et al. Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. J Infect Dis 2009;200:1216-1226.
31. Heller T, Rehermann B. Acute hepatitis C: a multifaceted disease. Semin Liver Dis 2005;25:7-17.
32. 32. Logvinoff C, Major ME, Oldach D, et al. Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc Natl Acad Sci USA 2004; 101:10149-10154. (Pubitemid 38891210)
33. 33. Chen M, Sällberg M, Sönnerborg A, et al. Limited humoral response immunity in hepatitis C virus infection. Gastroenterology 1999; 116: 135-143. (Pubitemid 29013502)
34. Nikolaeva LI, Blokhina NP, Tsurikova NN, et al. Virus-specific antibody titers in different phases of hepatitis C virus infection. J Viral Hepat 2002;9:429-1137
35. 35. Takaki A, Wiese M, Maertens G, et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 2000;6:578-582. (Pubitemid 30305910)
36. Huang WS, Lu SN, Wang JH, et al. Prediction of viremia for cases of hepatitis C virus (HCV) infection using a third-generation anti-HCV enzyme immunoassay test. Hepatogastroenterology 2005;52:893-896.
37. Lu SN, Tung HD, Chen TM, et al. Is it possible to diagnose acute hepatitis C virus (HCV) infection by a rising anti-HCV titre rather than by seroconversion? J Viral Hepat 2004; 11:563-570.
38. 38. Shata MT, Tricoche N, Perkus M, et al. Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees. Virology 2003; 314: 601-616. (Pubitemid 37209981)